Chargement en cours...
Harnessing antitumor immunity: Employment of tumor recall antigens to optimize the inflammatory response to cancer
The advent of immunotherapy for cancer has contributed to the era of personalized medicine for cancer. The various immunotherapy-based treatments that have been explored thus far include monoclonal antibody therapy, tumor vaccines, immune checkpoint blockade and adoptive T cell transfer, among other...
Enregistré dans:
| Publié dans: | Oncol Lett |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5403274/ https://ncbi.nlm.nih.gov/pubmed/28454356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5721 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|